Veridia Labs is building India's integrated multi-omics and precision medicine ecosystem. Combining deep scientific expertise with a robust operational and financial backbone, we provide the capabilities required to localize, validate, and scale advanced diagnostic and precision medicine solutions across India.
We work with hospitals, diagnostic laboratories, life sciences companies, academia, public funded research institutes, and biopharma innovators to deliver rapid, compliant, and cost-effective execution.
Veridia Labs is led by a team of industry veterans with deep expertise in molecular diagnostics, genomics, and life sciences commercialization across India and Asia.
Co-Founder & CEO
Commercial leader with 27+ years of experience in molecular diagnostics, genomics, and medtech. Former General Manager at Thermo Fisher Scientific, where he led nationwide growth for Genetic Sciences and Clinical Sequencing businesses in India and Southeast Asia.
BITS Pilani • IIM Ahmedabad
Co-Founder & Director — Strategy & Business Development
Life Sciences veteran with 22 years of experience in bioinformatics and genomic innovation, including a high-impact tenure at Thermo Fisher Scientific. Specializes in scaling NGS, dPCR, and multi-omics initiatives through strategic partnerships.
MSc • Executive MBA, IIM Calcutta
Co-Founder & Director — Commercial
Seasoned clinical genomics and business development professional with 18 years of experience across South Asia. Ph.D. from JNU with research on genetic heterogeneity in breast cancer. Previously Country Head — NGS Business Development at Thermo Fisher Scientific.
Ph.D., JNU • Executive MBA, IIM Calcutta
With core strengths in oncology and transplant diagnostics, we are building capabilities that extend across multiple therapeutic and diagnostic domains.
Advanced molecular and precision diagnostic approaches for cancer care.
Molecular monitoring and donor-recipient compatibility solutions for solid organ and hematopoietic stem cell transplantation.
Emerging genomic workflows for complex and inherited conditions.
Supporting evolving molecular applications in reproductive health.
Exploring personalized therapeutic strategies informed by genomic variation.
Enabling molecular approaches for future precision medicine programs.
Two globally respected partners, each chosen for their complementary strengths — together enabling Veridia Labs to deliver world-class molecular diagnostics across India.
A German innovator in molecular precision diagnostics, BIOTYPE develops integrated platforms that bring depth, accuracy, and reliability to clinical biomarker analysis.
Proprietary instrument-and-assay systems built for clinical precision
Co-development and contract manufacturing capabilities
A globally established Turkish manufacturer of molecular diagnostic solutions with 20+ years of expertise, serving 60+ countries with a broad and scalable product portfolio.
Proprietary instrument-and-assay systems built for clinical precision
Proprietary instrument-and-assay systems built for clinical precision
Veridia Labs works with strategic collaborators across healthcare, diagnostics, and life sciences to advance precision medicine in India.
If your organization is exploring precision medicine, molecular diagnostics, genomics infrastructure, or translational medicine initiatives, we invite you to connect.
Whether you're exploring precision medicine initiatives or looking for a strategic partner in molecular diagnostics, we'd love to hear from you.
Email: sales@veridialabs.in
Address:
Veridia Labs Private Limited
Regus Business Centre
9th Floor, Brigade IRV Centre
Nallurhalli Road, Whitefield
Bengaluru-560066, India